1 / 43

Hypertensive Emergencies

Jason R. Frank MD MA(Ed) FRCPC Dept of Emergency Medicine. Hypertensive Emergencies. Case 1. Case 1. 82 yo female CC: acute onset severe headache, n/v Noted by family to be confused Denies trauma PMHx: HTN, elevated cholesterol. Your Assessment. VS: HR-110, BP-230/150

aglaia
Download Presentation

Hypertensive Emergencies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Jason R. FrankMD MA(Ed) FRCPC Dept of Emergency Medicine Hypertensive Emergencies

  2. Case 1

  3. Case 1 • 82 yo female • CC: acute onset severe headache, n/v • Noted by family to be confused • Denies trauma • PMHx: HTN, elevated cholesterol

  4. Your Assessment • VS: HR-110, BP-230/150 RR 32, O2 96% RA • GCS 14 (speech confused) • No focal neurological signs • No signs of trauma • CVS/Resp: bilateral crackles

  5. What now? • What concerns you about this pt? • Differential diagnosis? • Investigations? • Immediate management?

  6. Concerning Features • VS: HR-110, BP-230/150 RR 32, O2 96% RA • GCS 14 (speech confused) • No focal neurological signs • No signs of trauma • CVS/Resp: bilateral crackles

  7. Differential Diagnosis 62 yo with headache, confusion, HTN • CVA • ICH: spontaneous, traumatic • CNS Infection: meningitis, encephalitis, abscess • CNS neoplasm: primary or mets • Migraine HA • Metabolic or toxic encephalopathy • Hypertensive encephalopathy

  8. MCC Objectives

  9. MCC OBJECTIVES – HTN EM KEY objectives: • Differentiate “malignant” HTN from secondary conditions • Conduct initial HTN lowering treatment OBJECTIVES: • Differentiate non-localizing neurologic symptoms • Determine presence of other hypertensive emergencies • Interpret clinical & lab findings • Conduct an effective management plan, including specific Rx

  10. HYPERTENSION Standard Definition • Based on 3 measurements, each 1 wk apart > 140 systolic > 90 diastolic • Most important # acutely: Diastolic • MAP = 1/3 Systolic, 2/3 Diastolic

  11. Primary or Secondary • Majority (90-95%) essential HTN • Of Secondary: ½ have a potentially curable cause

  12. Secondary HTN Increased CO: • RF with fluid overload • Acute renal disease • Hyperaldosteronism • Cushing’s syndrome • Coarctation of the Aorta Increased vascular resistance: • Renal Artery Stenosis • Pheochromocytoma • Drugs • Cerebrovascular (CVA, ICH, SAH)

  13. Renal Artery Stenosis • most common treatable cause (1-5%) • compromised renal perfusion => activation of RAA • 2 pt groups: • Elderly with atherosclerotic disease • Young females with fibromuscular dysplasia • Clinical: abdo bruit (40-80%), retinopathy, HTN resistant to Rx, hypoK

  14. Aldosteronism • Uncommon but treatable • Na retention, volume expansion, increased CO • Hypernatremia & Hypokalemia typical • Primary: Adrenal adenoma, hyperplasia • Secondary: Cushing’s, CAH, exogenous mineralcorticoids

  15. Pheochromocytoma • Tumour, usually in adrenal medulla • Produces xs catecholamines (epi, NE) • Paroxysmal HTN…difficult to recognize • Episodic HTN, HA, palpitations, diaphoresis, anxiety…not a panic attack! • Easy to diagnose: elevated urinary catecholamines, metanephrines, vandillylmandelic acid

  16. Coarctation of the Aorta • Rare but early surgical intervention can improve prognosis • Clinical triad: • upper extremity HTN • systolic murmur over back • delayed femoral pulses

  17. Drugs • Cocaine, amphetamines • ETOH withdrawal • Withdrawal from clonidine, beta blocker • MAOI + tyramine containing foods or certain Rx (meperidine, TCA, ephedrine) • Tyramine causes release of NE • Usually rapidly destroyed by MAO

  18. Thinking About HTN: • Chronic HTN • Transient HTN • “White coat HTN” • Hypertensive “Urgencies” • Hypertensive “Emergencies”

  19. Hypertensive “Urgencies” • Elevated BP WITHOUT evidence of acute end-organ damage • BP arbitrary levels • In past, treated with SL nifedipine • Demonstrated adverse outcomes (stroke, MI) • “rarely requires therapy” • Consider initiating chronic Rx

  20. Malignant Hypertension Severe HTN & Evidence of acute end-organ damage • Diastolic BP usually > 130 mm Hg or MAP > 160 • Relative rise much more important than # • Affects 1% of hypertensive patients

  21. End-Organ Damage • CNS: Hypertensive encephalopathy • CVS: Cardiac Ischemia Pulmonary Edema Aortic Dissection • Renal: ARF • Heme: microangiopathic hemolytic anemia • Eclampsia/Pre-eclampsia

  22. Case 1 • 62 yo female • CC: acute onset severe headache, n/v • Noted by family to be confused • Denies trauma • PMHx: HTN, elevated cholesterol

  23. Your Assessment • VS: HR 110, BP 230/150, RR 32, O2 96% RA • GCS 14 • No focal neurological signs • No signs of trauma • CVS/Resp: bilateral crackles

  24. Case 1 • What is your initial management for this pt? • What is causing her symptoms?

  25. Cerebral Perfusion • Autoregulation: cerebral blood flow maintained through normal range of BP by afferent arterioles • N: autoregulation for MAP > 60 • Chronic HTN: level of autoregulation in elevated

  26. Hypertensive Encephalopathy Abrupt, sustained raised in BP (DBP > 140) => exceeds capacity of autoregulation uncontrolled cerebral blood flow vasospasm, ischemia, punctate hemorrhages, increased vascular permeability => ischemia, cerebral edema

  27. Hypertensive Encephalopathy: Clinical • Acute in onset & reversible • Severe HA, N/V, drowsiness, confusion • +/- seizures, coma, focal neurological deficits, blindness • Papilledema usually present • EMERGENCY….untreated pts may die within hrs!

  28. How to Differentiate? • Focal deficits do not usually follow a singular anatomic pattern • Onset: usually hours to days • Can be associated with hemorrhage • CT usually N • EEG non-specific • CSF: clear, increased opening pressure

  29. Management ABC’s Control BP! • Goal reduce MAP by 25% or diastolic to minimum of 110 mm Hg over 1 hr • IV Nitroglycerine • IV Nitroprusside • Labetolol: selective alpha & non-selective beta blocker

  30. Physical Exam in HTN • Eye: • Acute: papilledema, retinal hemorrhages, vasospasm • Chronic: AV nicking, cotton wool spots, silver wiring • CVS: • Pulm edema: S3, rales JVD, peripheral edema • LVH: displaced apex • Coarctation murmur • Renal • Bruit • Fluid overload

  31. Other End-Organ Effects

  32. Cardiovascular End-Organ Damage • Pulmonary Edema • Aortic Dissection • ACS

  33. Pulmonary Edema • Long standing HTN  myocardial hypertrophy • Eventually leads to LVF & dilatation • Stress of pulmonary edema  to xs catecholamines leading to HTN • Standard treatment causes fall in levels & BP returns to normal

  34. Pulmonary Edema • In some, sudden, severe HTN precipitates acute LVF, causing pulmonary edema • BP must be lowered to reverse the process

  35. Management of Pulmonary Edema • Standard Therapy: nitrates, O2, Furosemide, ACEI Focused antihypertensive Rx: • Nitroglycerin IV • Nitroprusside IV • ACEI as an adjunct

  36. Cardiac Ischemia • If severe HTN associated with angina, lower BP to prevent myocardial damage • Nitroglycerin SL, IV • Beta-blockers (careful in setting of poor LVF) • ACEI • Nitroprusside NOT used as may cause reflex tachycardia

  37. Aortic Dissection • Classic: acute onset ‘tearing” chest pain radiating to back • Widened mediastinum on CXR • CT angio modality of choice • Immediate control of BP to limit extent of dissection • Type A: involve ascending Ao, Tx: OR • Type B: treated medically

  38. Management Aortic Dissection • Goal to reduce BP to sys 100-120 mm Hg • Reduce ejection force of heart • Rx • Vasodilator (e.g. nitroprusside, fendolopam) PLUS Beta blocker • Or monotherapy with Labetolol (alpha/beta blocker)

  39. Acute Renal Failure • Urine dip: protein, RBC • Labs: BUN, Cr, electrolytes • Management • Nitroprusside IV, Labetolol IV • ACE-I, although takes a few hours • CCB IV (nicardipine)

  40. Specific Therapies in Acute Hypertensive Emergencies • Labetolol • 20mg IV, may incrementally increase dose (40mg, 80mg) q20 min, max 300mg/24 hr • Nitroprusside: 0.3 mcg/kg/min, titrate up to 10 mcg/kg/min • Nitroglycerin: start at 10-20 mcg/min, titrate up • Special cases: Eclampsia, pre-eclampsia • MgSO4(for seizures) 4-6gm/1 hr • Hydralazine 10 mg IV

  41. Acute Hypertension: Overview • Most pts do NOT require emergent treatment for their HTN (do no harm) • With severe HTN, evaluate immediately for end-organ effects • Appropriate BP measurement • Rapid recognition & appropriate reduction in BP for hypertensive emergencies • Careful of over-treatment of HTN & risk of cerebral ischemia

  42. Jason R. FrankMD MA(Ed) FRCPC Dept of Emergency Medicine Hypertensive EmergenciesQuestions?

More Related